Company: PHR
Filing Date: 2025-03-13
Form Type: 10-K
Source: 0001412408-25-000010
Chunk: 27

Company: Phreesia, Inc.
Filing Date: 2025-03-13
Form: 10-K
Item: Item 8
Chunk 27
---
 the Company capitalized $16,846, $19,521 and $23,604 of costs related to the Company's solutions, respectively.During the fiscal years ended January 31, 2025, 2024 and 2023 amortization expense related to capitalized internal-use software was $10,222, $9,527 and $5,945, respectively. (e) Intangible assets and goodwillThe following presents the details of intangible assets as of January 31, 2025 and 2024.Useful LifeJanuary 31,(years)20252024Acquired technology5 to 7$9,310 $9,310 Customer relationship7 to 1517,940 17,940 License156,200 6,200 Trademarks153,100 3,100 Total intangible assets, gross carrying value$36,550 $36,550 Less: accumulated amortization(8,407)(4,925)Net carrying value$28,143 $31,625 The weighted average remaining useful life for acquired technology in years was 5.1 and 6.0 as of January 31, 2025 and 2024, respectively. The remaining useful life for customer relationships in years was 11.6 and 12.4 as of January 31, 2025 and 2024, respectively. The remaining useful life for the license to the Patient Activation Measure ("PAM"®) in years was 11.8 and 12.8 as of January 31, 2025 and 2024, respectively. The remaining useful life for the trademarks in years was 13.5 and 14.5 as of January 31, 2025 and 2024, respectively.Amortization expense associated with intangible assets for the fiscal years ended January 31, 2025, 2024 and 2023 was $3,481, $2,376 and $1,371, respectively.The estimated amortization expense for intangible assets for the next five years and thereafter is as follows as of January 31, 2025:January 31, 20252026$3,450 20273,157 20283,157 20293,057 Thereafter15,322 Total$28,143 The following table presents a roll-forward of goodwill for the years ended January 31, 2025 and 2024:Balance, January 31,